Tech Company Financing Transactions
Elcelyx Therapeutics Funding Round
Elcelyx Therapeutics secured a $1.2 million funding round on 3/18/2010. Backers included Morgenthaler Ventures.
Transaction Overview
Company Name
Announced On
3/18/2010
Transaction Type
Venture Equity
Amount
$1,200,000
Round
Undisclosed
Investors
Morgenthaler Ventures (Ralph Christofferson)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11995 El Camino Real 305
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
40% of treated type 2 diabetes patients are not able to take metformin, the first-line and foundational therapy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alain Baron
Chief Financial Officer
Jay Sherwood
Chief Scientific Officer
Mark Fineman
VP - Regulatory Affairs
Thomas Bicsak
Browse more venture capital transactions:
Prev: 3/17/2010: LiveTimeNet venture capital transaction
Next: 3/18/2010: Formspring venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs